Diabetic dyslipidaemia: from basic research to clinical practice* (original) (raw)

• Turner R C, Millns H, Neil HAW et al. (1998) Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS:23). BMJ 316:823–828
  CAS PubMed Google Scholar
• Isomaa B, Lahti K, Almgren P et al. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683–689
  CAS PubMed Google Scholar
• Zimmet P, Alberti KGMM, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787
  Article CAS PubMed Google Scholar
• Haffner S M, Lehto S, Rönnemaa T et al. (1998) Mortality from coronary heart diseases in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234
  CAS PubMed Google Scholar
• Malmberg K, Yusuf S, Gerstein H C et al. (2000) Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wawe myocardial infarction. Circulation 102:1014–1019
  CAS PubMed Google Scholar
• Executive summary of the third report of the National Cholesterol Education Program (NCEP) (2001) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497
  PubMed Google Scholar
• Syvänne M, Taskinen M-R (1997) Lipids and lipoproteins as coronary risk factors in non-insulin dependent diabetes mellitus. Lancet 350 [Suppl 1]:20–23
• Taskinen M-R (2001) Pathogenesis of dyslipidemia in type 2 diabetes. Exp Clin Endocrinol Diabetes 109:173–181
  Article Google Scholar
• Ginsberg HN (2002) New perspectives in atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism. Circulation 106:2137–2142
  Article PubMed Google Scholar
• Packard CJ, Shepherd J (1997) Lipoprotein heterogeneity and apolipoprotein B metabolism. Aterioscler Thromb Vasc Biol 17:3542–3556
  CAS Google Scholar
• Taskinen M-R (1987) Lipoprotein lipase in diabetes. Diabet/Metab Rev 3:551–570
  Google Scholar
• Kasim SE, Tseng K, Jen K-LC et al. (1987) Significance of hepatic triglyceride lipase activity in the regulation of serum high density lipoproteins in type II diabetes mellitus. J Clin Endocrinol Metab 65:183–187
  CAS PubMed Google Scholar
• Baynes C, Henderson A D, Anyaoku V et al. (1991) The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes. Diabet Med 8:560–566
  CAS PubMed Google Scholar
• Tan KCB, Shiu SWM, Chu BYM (1999) Roles of hepatic lipase and cholesteryl ester transfer protein determining low density lipoprotein subfraction distribution in Chinese patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 145:273–278
  Article CAS PubMed Google Scholar
• Tan CE, Forster L, Caslake MJ et al. (1995) Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and women. Arterioscler Thromb Vasc Biol 15:1839–1848
  CAS PubMed Google Scholar
• McEneny J, O'Kane MJ, Moles KW et al. (2000) Very low density lipoprotein subfractions in type 2 diabetes mellitus: alterations in composition and susceptibility to oxidation. Diabetologia 43:485–493
  Article CAS PubMed Google Scholar
• Taskinen M-R, Packard CJ, Shepherd J (1990) Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM. Diabetes 39:1017–1027
  CAS PubMed Google Scholar
• Guérin M, Le Goff W, Lassel TS et al. (2001) Proatherogenic role of elevated CE transfer from HDL to VLDL 1 and dense LDL in type 2 diabetes. Arterioscler Thromb Vasc Biol 21:282–288
  PubMed Google Scholar
• Leinonen ES, Leinonen PJ, Salonen JT et al. (2002) Reduced IGFBP-1 is associated with thickening of the carotid wall in type 2 diabetes. Diabetes Care 25:1807–1812
  CAS PubMed Google Scholar
• Shachter NS (2001) Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol 12:297–304
  Article CAS PubMed Google Scholar
• Wang CS, McConathy WJ, Kloer HU et al. (1985) Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest 75:384–390
  CAS PubMed Google Scholar
• Ebra T, Ramakrishnan R, Steiner G et al. (1997) Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein. Eur J Clin Invest 99:2672–2681
  Google Scholar
• Sehayek E, Eisenberg S (1991) Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J Biol Chem 266:18259–18267
  CAS PubMed Google Scholar
• Briones ER, Mao SJ, Palumbo PJ et al. (1984) Analysis of plasma lipids and apolipoproteins in insulin-dependent and non-insulin-dependent diabetics. Metabolism 33:42–49
  CAS PubMed Google Scholar
• Campos H, Perlov D, Khoo C et al. (2001) Distinct patterns of lipoproteins with apo B defined by presence of apo E or apoC-III in hypercholesterolemia and hypertriglyceridemia. J Lipid Res 42:1239–1249
  CAS PubMed Google Scholar
• Tomiyasu K, Walsh BW, Ikewaki K et al. (2001) Differential metabolism of human VLDL according to content of ApoE and ApoC-III. Arterioscler Thromb Vasc Biol 21:1494–1500
  CAS PubMed Google Scholar
• Sacks FM, Alaupovic P, Moye LA et al. (2000) VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE) trial. Circulation 102:1886–1892
  CAS PubMed Google Scholar
• Luc G, Fievet C, Arveiler D et al. (1997) Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Temoins sur Infarctus du Myocarde. J Lipid Res 37:508–517
  Google Scholar
• Gervaise N, Garrigue M A, Lasfargues G et al. (2000) Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type 2 diabetes. Diabetologia 43:703–708
  Article CAS PubMed Google Scholar
• Gabor J, Spain M, Kalant N (1980) Composition of serum very-low-density and high-density lipoproteins in diabetes. Clin Chem 26:1261–1265
  CAS PubMed Google Scholar
• Stalenhoef AFH, Demacker PNM, Lutterman JA et al. (1982) Apolipoprotein C in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia. Diabetologia 22:489–491
  CAS PubMed Google Scholar
• Ishibashi S, Yamada N, Shimano H et al. (1989) Composition of very-low-density lipoproteins in non-insulin-dependent diabetes mellitus. Clin Chem 35:808–812
  CAS PubMed Google Scholar
• Mahley RW, Ji S-Z (1999) Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein. Eur J Lipid Res 40:1–16
  CAS Google Scholar
• Syvänne M, Rosseneu M, Labeur C et al. (1994) Enrichment with apolipoprotein E characterizes postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: preliminary report. Atherosclerosis 105:25–34
  PubMed Google Scholar
• Tannock LR, Olin KL, Barret HR et al. (2002) Triglyceride-rich lipoproteins from subjects with type 2 diabetes do not demonstrate increased binding to biglycan, a vascular proteoglycan. J Clin Endocrinol Metab 87:35–40
  CAS PubMed Google Scholar
• Sparks JD, Sparks CE (1994) Insulin regulation of triglycerol-rich lipoprotein synthesis and secretion. Biochim Biophys Acta 1215:9–32
  Article CAS PubMed Google Scholar
• Zammit V A (1996) Role of insulin in hepatic fatty acid partitioning: emerging concepts. Biochem J 314:1–14
  CAS PubMed Google Scholar
• Chirieac D V, Chirieac L R, Corsetti J P et al. (2000) Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production. Am J Endocrinol Metab 279: E1003–E1011
  CAS Google Scholar
• Lin MCM, Gordon D, Wetterau JR (1995) Microsomal triglyceride transfer protein (MTP) regulation in HEPG2 cells: insulin negatively regulates MTP gene expression. J Lipid Res 36:1073–1081
  CAS PubMed Google Scholar
• Kuriyama H, Yamashita S, Shimomura I et al. (1998) Enhanced expression of hepatic acyl-coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation. Hepatology 27:557–562
  CAS PubMed Google Scholar
• Bartels ED, Lauritsen M, Nielsen LB (2002) Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice. Diabetes 51:1233–1239
  CAS PubMed Google Scholar
• Taghibiglou C, Carpentier A, Van Iderstine SC et al. (2000) Mechanism of hepatic very low density lipoprotein overproduction in insulin resistance. J Biol Chem 275:8416–8425
  Article CAS PubMed Google Scholar
• Carpentier A, Taghibiglou C, Leung N et al. (2002) Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. J Biol Chem 277:28795–28802
  Article CAS PubMed Google Scholar
• Marsh JB, Welty FK, Lichtenstein AH et al. (2002) Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors. Atherosclerosis 162:227–244
  Article CAS PubMed Google Scholar
• Packard CJ, Demant T, Stewart JP et al. (2000) Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res 41:305–317
  CAS PubMed Google Scholar
• Tan CE, Forster L, Caslake MJ et al. (1995) Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and women. Arterioscler Thromb Vasc Biol 15:1839–1848
  CAS PubMed Google Scholar
• Malmström R, Packard CJ, Watson TDG et al. (1997) Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol 17:1454–1464
  PubMed Google Scholar
• Lewis GF, Uffelman KD, Szeto LW et al. (1993) Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL ApoB production in normal weight and obese individuals. Diabetes 42:833–842
  CAS PubMed Google Scholar
• Bioletto S, Golay A, Munger R et al. (2000) Acute hyperinsulinemia and very-low-density lipoprotein subfractions in obese subjects. Am J Clin Nutr 71:443–449
  CAS PubMed Google Scholar
• Malmström R, Packard CJ, Caslake M et al. (1997) Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 40:454–462
  Article CAS PubMed Google Scholar
• Gibbons GF, Islam K, Pease RJ (2000) Mobilisation of triglycerol stores. Biochim Biophys Acta 1483:37–57
  Article CAS PubMed Google Scholar
• Olofsson S-O, Stillemark-Bilton P, Asp L (2000) Intracellular assembly of VLDL: two major steps in separate cell compartments. Trends Cardiovasc Med 10:338–345
  Article CAS PubMed Google Scholar
• Lewis GF, Carpentier A, Adeli K et al. (2002) Disordered fat storage and mobolization in the pathogenesis of insulin resistance ond type 2 diabetes. Endocr Rev 23:201–229
  CAS PubMed Google Scholar
• Phung TL, Roncone A, De Mesy Jensen KL et al. (1997) Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum. Journal of Biological Chemistry 272:30693–30702
  Article CAS PubMed Google Scholar
• Brown AM, Gibbons GF (2001) Insulin inhibits the maturation phase of VLDL assembly via a phosphoinositide 3-kinase-mediated event. Arterioscler Thromb Vasc Biol 21:1656–1661
  CAS PubMed Google Scholar
• Shimomura I, Matsuda M, Hammer RE et al. (2000) Decreased IRS-2 and increased SREBP-1 lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6:77–86
  CAS PubMed Google Scholar
• Foufelle F, Ferré P (2002) New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol ragulatory element binding protein-1c. Biochem J 366:377–391
  Article CAS PubMed Google Scholar
• Matsumoto M, Ogawa W, Teshigawara K et al. (2002) Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes. Diabetes 51:1672–1680
  CAS PubMed Google Scholar
• Yahagi N, Shimano H, Hasty AH et al. (2002) Absence of sterol regulatory element-binding Protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lepob/Lepob mice. J Biol Chem 277:19353–19357
  Article CAS PubMed Google Scholar
• Malmström R, Packard CJ, Caslake M et al. (1998) Effects of insulin and acipimox on VLDL 1 and VLDL 2 apolipoprotein B production in normal subjects. Diabetes 47:779–787
  PubMed Google Scholar
• Malmström R, Packard CJ, Caslake M et al. (1999) Effect of heparin-stimulated plasma lipolytic activity on VLDL apo B subclass metabolism in normal subjects. Atherosclerosis 146:381–390
  Article PubMed Google Scholar
• Carpentier A, Patterson BW, Leung N et al. (2002) Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans. Diabetes 51:1867–1875
  CAS PubMed Google Scholar
• Ginsberg HN (2000) Insulin resistance and cardiovascular disease. J Clin Invest 106:453–458
  CAS PubMed Google Scholar
• Kissebah AH, Alfarasi S, Evans DJ et al. (1982) Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus. Diabetes 31:217–225
  CAS PubMed Google Scholar
• Taskinen MR, Beltz WF, Harper I et al. (1986) Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Study before and after sulfonylurea therapy. Diabetes 113:522–526
  Google Scholar
• Cummings MH, Watts GF, Umpleby AM et al. (1995) Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetologia 38:959–967
  Article CAS PubMed Google Scholar
• Howard BV, Abbot WGH, Egusa G, Taskinen MR (1987) Coordination of very-low-density lipoprotein triglyceride and apolipoprotein B metabolism in humans: effect of obesity and non-insulin-dependent diabetes mellitus. Am Heart J 113:522–556
  CAS PubMed Google Scholar
• Duvillard L, Pont F, Florentin E et al. (2000) Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study. Eur J Clin Invest 30:685–694
  Article CAS PubMed Google Scholar
• Ryysy L, Häkkinen A-M, Goto T et al. (2000) Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49:749–758
  CAS PubMed Google Scholar
• Marchesini G, Brizi M, Bianchi G et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844–1850
  CAS PubMed Google Scholar
• Clark JM, Diehl AM (2002) Hepatic steatosis and type 2 mellitus. Current diabetes reports 2:210–215
  PubMed Google Scholar
• Seppälä-Lindroos A, Vehkavaara S, Häkkinen A-M et al. (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87:3023–3028
  PubMed Google Scholar
• Yki-Järvinen H (2002) Ectopic fat accumulation: an important cause of insulin resistance in humans. J R Soc Med 95 [Suppl 42]: 39–45
• De Vegt F, Dekker JM, Ruhé HG et al. (1999) Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn study. Diabetologia 42:926–931
  PubMed Google Scholar
• The Decode Study Group (2001) Glucose tolerance and cardiovascular mortality. Arch Intern Med 161:397–404
  PubMed Google Scholar
• Heine RJ, Balkau B, Ceriello A et al. (2003) What does post-prandial hyperglycaemia mean? Diabet Med (in press)
• De Man FHAF, Castro Cabezas N, van Barlingen HJJ et al. (1996) Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis. Eur J Clin Invest 26:89–108
  PubMed Google Scholar
• Ginsberg HN, Illingworth R (2001) Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus. Am J Cardiol 88 [Suppl]:H9–H15
  Google Scholar
• Syvänne M, Hilden H, Taskinen M-R (1994) Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease. J Lipid Res 35:15–26
  PubMed Google Scholar
• Heine RJ, Dekker J M (2002) Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease. Diabetologia 45:461–475
  CAS PubMed Google Scholar
• Schneeman BO, Kotite L, Todd KM et al. (1993) Relationship between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to fat containing meal in normolipidemic humans. Proc Natl Acad Sci USA 90:2069–2073
  CAS PubMed Google Scholar
• Karpe F, Bell M, Björkegren J et al. (1995) Quantification of postprandial triglyceride-rich lipoproteins in healthy men by Retinyl Ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100. Arterioscler Thromb Vasc Biol. 15:199–207
  Google Scholar
• Vakkilainen J, Mero N, Schweizer A et al. (2002) Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes. Diabetes Metab Res Rev 18:484–490
  Article CAS PubMed Google Scholar
• Karpe F, Olivercrone T, Hamsten A et al. (1997) Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants. J. Lipid Res 38:949–961
  CAS Google Scholar
• Goldberg IJ, Kako Y, Lutz EP (2000) Responses to eating: lipoproteins, lipolytic products and atherosclerosis. Curr Opin Lipidol 11:235–241
  Article CAS PubMed Google Scholar
• Tomkin GH, Owens D (2001) Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis. Diabetes Metab Res Rev 17:27–43
  Article CAS PubMed Google Scholar
• Panarotto D, Rémillard P, Bouffard L et al. (2002) Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner. Eur J Clin Invest 32(2):84–92
  Article CAS Google Scholar
• Mero N, Suurinkeroinen L, Syvänne M et al. (1999) Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant; relationship to insulin sensitivity. J Lipid Res 40:1663–1670
  CAS PubMed Google Scholar
• Talmud PJ (2001) Genetic determinants of plasma triglycerides: impact of rare and common mutations. Curr Atheroscler Rep 3:191–199
  CAS PubMed Google Scholar
• Ebra T, Conde K, Kako Y et al. (2000) Delayed catabolism of apo B48 lipoproteins due to decreased heparin sulphate proteoglycan production in diabetic mice. J Clin Invest 105:1807–1818
  PubMed Google Scholar
• Haidari M, Leung N, Mahbub F et al. (2002) Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. J Biol Chem 277:31646–31655
  Article CAS PubMed Google Scholar
• Fard A, Tuck CH, Donis JA et al. (2000) Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 20:2039–2044
  Google Scholar
• Evans M, Anderson RA, Graham J et al. (2000) Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. Circulation 101:1773–1779
  CAS PubMed Google Scholar
• Rongen GA, Tack CJ (2001) Triglycerides and endothelial function in type 2 diabetes. Eur J Clin Invest 31:560–562
  Article CAS PubMed Google Scholar
• Ceriello A, Taboga C, Tonutti L et al. (2002) Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation. Circulation 106:1211–1218
  Article PubMed Google Scholar
• Flood C, Gustafsson M, Richardson PE et al. (2002) Identification of the proteoglycan binding site in apolipoprotein B48. J Biol Chem 277(35): 32228–32233
  Article CAS PubMed Google Scholar
• Skålen K, Gustafsson M, Rydberg EK et al. (2002) Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417:750–754
  Article PubMed Google Scholar
• Doi H, Kugiyama K, Oka H et al. (2000) Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation 102:670–676
  CAS PubMed Google Scholar
• Anderson RA, Jones CJH, Goodfellow J (2001) Hypothesis: is the fatty meal a trigger for acute coronary syndromes. Atherosclerosis 159:9–15
  Article CAS PubMed Google Scholar
• Austin MA, Breslow JL, Hennekens CH et al. (1988) Low-density lipoprotein subclass patterns and risk of myocardial infraction. JAMA 260:1917–1921
  CAS PubMed Google Scholar
• Hurt-Camejo E, Camejo G, Sartipy P (2000) Phospholipase A2 and small, dense low-density lipoprotein. Curr Opin Lipidol 11:465–471
  Article CAS PubMed Google Scholar
• Otvos JD, Jayarajah EJ, Cromwell WC (2002) Measurements issues related to lipoprotein heterogeneity. Am J Cardiol 90 [Suppl]:I22–I29
  Google Scholar
• Boren J, Lee I, Zhu W et al. (1998) Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective Apo-B100. J Clin Invest 101:1084–1093
  CAS PubMed Google Scholar
• Sniderman AD, Scantlebury T, Cianflone K (2001) Hypertriglyceridemic HyperapoB: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med 135:447–459
  CAS PubMed Google Scholar
• Tilly-Kiesi M, Syvänne M, Kuusi T et al. (1992) Abnormalities of low density lipoproteins in normolipidemic type 2 diabetic and nondiabetic patients with coronary artery disease. J Lipid Res 33:333–342
  CAS PubMed Google Scholar
• Stewart MW, Laker MF, Dyer RG et al. (1993) Lipoprotein compositional abnormalities and insulin resistance in type 2 diabetic patients with mild hyperlipidemia. Arterioscl Thromb Vasc Biol 13:1046–1052
  CAS Google Scholar
• Lahdenperä S, Syvänne M, Kahri J et al. (1996) Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides. Diabetologia 39:453–461
  Article CAS PubMed Google Scholar
• Gray RS, Robbins DC, Wang Wenyu et al. (1997) Relation of LDL size to the insulin resistance syndrome and coronary heart disease in american indians. Arterioscler Thromb Vasc Biol 17:2713–2720
  CAS PubMed Google Scholar
• Feingold KR, Grunfield C, Pang M et al. (1992) LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb 12:1496–1502
  CAS PubMed Google Scholar
• Caixàs A, Ordóñez-Llanos J, Leiva A de et al. (1997) Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes 46:1207–1213
  PubMed Google Scholar
• Koba S, Hirano T, Yoshino G et al. (2002) Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes. Atherosclerosis 160:249–256
  Article CAS PubMed Google Scholar
• Lahdenperä S, Sane T, Vuorinen-Markkola H et al. (1994) LDL particle size in mildy hypertriglyceridemic subjects: no relation to insulin resistance or diabetes. Atherosclerosis 113:227–236
  Article Google Scholar
• Tchernof A, Moorjani S, Lamarche B et al. (1996) The dense LDL phenotype: association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 19:629–637
  CAS PubMed Google Scholar
• Ambrosch A, Dierkes J, Mühlen I et al. (1998) LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects. Diabetes Care 21:2077–2084
  CAS PubMed Google Scholar
• Rainwater DL (2000) Lipoprotein correlates of LDL particle size. Atherosclerosis 148:151–158
  Article CAS PubMed Google Scholar
• Austin MA, Breslow JL, Hennekens CH et al. (1988) Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260:1917–1921
  CAS PubMed Google Scholar
• Coresh J, Kwiterovich PO, Smith HH et al. (1993) Association of plasma triglyceride concentration and LDL particle diameter, density and chemical composition with premature coronary artery disease in men and women. J Lipid Res 34:1687–1697
  CAS PubMed Google Scholar
• Lamarche B, Tchernof A, Dagenals GR et al. (1997) Small, dense LDL particles and the risk of ischemic heart disease. Prospective results from the Québec Cardiovascular Study. Circulation 95:69–75
  CAS PubMed Google Scholar
• Gardner CD, Fortmann SP, Krauss RM (1996) Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276:875–881
  Article CAS PubMed Google Scholar
• St-Pierre AC, Ruel IL, Cantin B et al. (2001) Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 104:2295–2299
  CAS PubMed Google Scholar
• Vakkilainen J, Steiner G, Ansquer J-C et al. (2003) Relationships between LDL particle size, plasma lipoproteins and progression of coronary artery disease. The diabetes atherosclerosis intervention study (DAIS). Circulation 107:1733–1737
  Article PubMed Google Scholar
• Hogikyan RV, Galecki AT, Pitt B et al. (1998) Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes. J Clin Endocr Metab 83:1946–1952
  CAS PubMed Google Scholar
• Tan KC, Ai VH, Chow S et al. (1999) Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab 84:3212–3216
  CAS PubMed Google Scholar
• Vakkilainen J, Mäkimattila S, Seppälä-Lindroos A et al. (2000) Endothelial dysfunction in men with small LDL particles. Circulation 102:716–721
  CAS PubMed Google Scholar
• Mäkimattila S, Mäntysaari M, Liu M-L et al. (1999) Impaired endothelium-dependent vasodilation in type 2 diabetes. Diabetes Care 22:973–981
  PubMed Google Scholar
• Chapman MJ, Guérin M, Bruckert E (1998) Atherogenic, dense low-density lipoproteins: Pathophysiology and new therapeutic approaches. Eur Heart J 19 [Suppl A]:A24–A30
• Kornerup K, Nordestgaard BG, Feldt-Rasmussen B et al. (2002) Transvascular low-density lipoprotein transport in patients with diabetes mellitus (type 2): a noninvasive in vivo isotope technique. Arterioscler Thromb Vasc Biol 22:1168–1174
  Article CAS PubMed Google Scholar
• Galeano NF, Milne R, Marcel YL et al. (1994) Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J Biol Chem 269:511–519
  CAS PubMed Google Scholar
• Anber V, Griffin BA, Mc Connell M et al. (1996) Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 124:261–271
  Article CAS PubMed Google Scholar
• Galeano NF, Al-Haideri M, Keyserman F et al. (1998) Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenity. J Lipid Res 39:1263–1273
  CAS PubMed Google Scholar
• Chait A, Wight TN (2000) Interaction of native and modified low-density lipoproteins with extracellular matrix. Curr Opin Lipidol 11:451–456
  Article PubMed Google Scholar
• Tribble DL, Holl LG, Wood PD et al. (1992) Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 93:189–199
  CAS PubMed Google Scholar
• De Graaf J, Lemmers HLM, Hectors MPC et al. (1991) Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 11:198–306
  PubMed Google Scholar
• Lyons TJ, Jenkins AJ (1997) Lipoprotein glycation and its metabolic consequences. Current Opin Lipidol 8:174–180
  CAS Google Scholar
• Onorato JM, Jenkins AJ, Thorpe SR et al. (2000) Pyridoamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridocamine. J Biol Chem 275:21177–21184
  Article CAS PubMed Google Scholar
• Dimitriadis E, Griffin M, Owens D et al. (1996) Lipoprotein composition in NIDDM. The effect of dietary oleic acid on composition and oxidisability and function of low and high density lipoproteins. Diabetologia 39:667–676
  Article CAS PubMed Google Scholar
• Scheffer PG, Bakker SJL, Popp-Snijders C et al. (2001) Composition of LDL determinant on its susceptibility to in vitro oxidation in patients with well-controlled type 2 diabetes. Diabetes Metab Res Rev 17:459–466
  Article CAS PubMed Google Scholar
• Chancharme L, Thérond P, Nigon F et al. (1999) Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL. Arterioscler Thromb Vasc Biol 19:810–820
  CAS PubMed Google Scholar
• Goldberg IJ (2001) Diabetic dyslipidemia: causes and consequences. J Clin Endocrin Metab 86:965–971
  CAS Google Scholar
• Syvänne M, Ahola M, Lahdenperä S et al. (1995) High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res 36:573–582
  PubMed Google Scholar
• Pascot A, Lemieux I, Prud'homme D et al. (2001) Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res 42:2007–2014
  CAS PubMed Google Scholar
• Syvänne M, Kahri J, Virtanen KS et al. (1995) HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus. Circulation 92(3):364–370
  PubMed Google Scholar
• Syvänne M, Castro G, Dengremont C et al. (1996) Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. Atherosclerosis 127:245–253
  Article PubMed Google Scholar
• Lamarche B, Rashid S, Lewis G F et al. (1999) HDL metabolism in hypertriglyceridemic states: an overview. Clin Chem Acta 286:145–161
  Article CAS Google Scholar
• Lamarche B, Uffelman KD, Carpentier A et al. (1999) Triglyceride enrichement of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest 103:1191–1199
  CAS PubMed Google Scholar
• Rashid S, Barrett HR, Uffelman KD et al. (2002) Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation. Arterioscler Thromb Vasc Biol 22:483–487
  Google Scholar
• Golay A, Zech L, Shi A-Z et al. (1987) High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL. J Clin Endocrinol Metab 65:512–518
  CAS PubMed Google Scholar
• Frénais R, Ouguerran K, Maugeais C et al. (1997) High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotype study. Diabetologia 40:578–583
  Article PubMed Google Scholar
• Pietzsch J, Juselius U, Nitzsche S et al. (1998) In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance. Diabetes 47:1928–1934
  CAS PubMed Google Scholar
• Frénais R, Nazih H, Ouguerram K et al. (2001) In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 86:1962–1967
  PubMed Google Scholar
• Von Eckardstein A, Nofer J-R, Assmann G (2001) High density lipoproteins and arteriosclerosis, role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 21:13–27
  PubMed Google Scholar
• Tu A-Y, Albers JJ (2001) Glucose regulates the transcriptions of human genes relevant to HDL metabolism: Responsive elements for peroxisome proliferator-activated receptor are involved in the regulation of phospholipid transfer protein. Diabetes 50:1851–1856
  CAS PubMed Google Scholar
• Riemens SC, Tol A van, Sluiter WJ et al. (1999) Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration. Diabetes 48:1631–1637
  CAS PubMed Google Scholar
• Miettinen H, Haffner SM, Lehto S et al. (1998) Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care 21:69–75
  CAS PubMed Google Scholar
• Mukamai KJ, Maclure M, Nesto RW et al. (2001) Impact of diabetes on long-term survival after acute myocardial infarction. Diabetes Care 24:1422–1427
  PubMed Google Scholar
• Haffner SM (2003) Management of dyslipidemia in adults with diabetes. Diabetes Care 26 [Suppl]:S83–S86
• Pyörälä K, Pedersen TR, Kjekshus J et al. (1997) Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care 20:614–621
  CAS PubMed Google Scholar
• Goldberg RB, Mellies MJ, Sacks FM et al. (1998) Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. Circulation 98:2513–2519
  CAS PubMed Google Scholar
• Sacks FM, Tonkin AM, Craven T et al. (2002) Coronary heart disease in patients with with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors. Circulation 105:1424–1428
  Article CAS PubMed Google Scholar
• Heart Protection Study Collaborative Group (2002) MRC/BHF heart production study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7–22
  Article PubMed Google Scholar
• Armitage J, Collins R (2000) Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials. Heart 84:357–360
  Article CAS PubMed Google Scholar
• U.K. Prospective diabetes study group (1997) Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care 20:1683–1687
  PubMed Google Scholar
• Diabetes atherosclerosis intervention study investigators (2001) Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis intervention study, a randomised study. The Lancet 357:905–910
  Article Google Scholar
• Gotto A, Farmer J A (2001) Pleiotropic effects of stations: do they mater? Curr Opin Lipidol 12:391–394
  Google Scholar
• McFarlane S I, Muniyappa R, Francisco R et al. (2002) Pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab 87(4):1451–1458
  CAS PubMed Google Scholar
• Liao JK (2002) Beyond lipid lowering: the role of statins in vascular protection. Int J Cardiol 86:5–18
  Article PubMed Google Scholar
• Bloomfield Rubins H, Robins SJ, Collins D et al. (2002) Diabetes, Plasma insulin and cardiovascular disease. Arch Intern Med 162:2597–2604
  Article PubMed Google Scholar
• Fruchart J-C, Duriwz P, Staels B (1999) Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr Opin Lipidol 10:245–257
  CAS PubMed Google Scholar
• Fruchart J-C, Staels B, Duriez P (2002) PPAR-alpha, lipoprotein metabolism, metabolic diseases and atherosclerosis. In: Fruchart J-C, Gotto AM Jr, Paoletti R, Staels B, Catapano AL (eds) Peroxisome Proliferator Activated Receptors: from basic science to clinical applications,18. Kluwer, Dordrecht, pp 63–79
• Chinetti G, Lestavel S, Bocher V et al. (2001) PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7:53–58
  CAS PubMed Google Scholar
• Singaraja RR, Fievet C, Castro G et al. (2002) Increased ABCA1 activity protects against atherosclerosis. J Clin Invest 110:35–42
  Article CAS PubMed Google Scholar
• Martens F, Visseren F, Lemay J et al. (2002) Metabolic and additional vascular effects of thiazolidinediones. Drugs 62:1463–1480
  CAS PubMed Google Scholar
• Duval C, Chinetti G, Trottein F et al. (2002) The role of PPARs in atherosclerosis. TRENDS in Molecular Medicine 8:422–430
  Article CAS PubMed Google Scholar
• Etgen GJ, Oldham BA, Johnson WT et al. (2002) A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-α/γ agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models. Diabetes 51:1083–1087
  CAS PubMed Google Scholar
• Lindén D, Lindberg K, Oscarsson J et al. (2002) Influence of peroxisome proliferator-activated receptor α agonist on the intracellular turnover and secreation of apolipoprotein (Apo) B-100 and ApoB-48. J Biol Chem 277:23044–23053
  Article PubMed Google Scholar
• Sugden MC, Bulmer K, Gibbons GF et al. (2002) Peroxisome-proliferator-activated receptor-α (PPARα) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin. Biochem J 364:361–368
  Article CAS PubMed Google Scholar
• Mayerson AB, Hundal RS, Dufour S et al. (2002) The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 51:797–802
  CAS PubMed Google Scholar
• Nichols AV, Krauss RM, Musliner TA (1986) Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol 128:417–431
  CAS PubMed Google Scholar